These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7626576)

  • 1. Compliance in amblyopia therapy: objective monitoring of occlusion.
    Fielder AR; Irwin M; Auld R; Cocker KD; Jones HS; Moseley MJ
    Br J Ophthalmol; 1995 Jun; 79(6):585-9. PubMed ID: 7626576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with occlusion therapy for childhood amblyopia.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR; ;
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6158-66. PubMed ID: 23882695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic monitoring of treatment compliance in patching for amblyopia.
    Simonsz HJ; Polling JR; Voorn R; van Leeuwen J; Meester H; Romijn C; Dijkstra BG
    Strabismus; 1999 Jun; 7(2):113-23. PubMed ID: 10420216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance.
    Awan M; Proudlock FA; Gottlob I
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1435-9. PubMed ID: 15790912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronically measured compliance with occlusion therapy for amblyopia is related to visual acuity increase.
    Loudon SE; Polling JR; Simonsz HJ
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):176-80. PubMed ID: 12644939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occlusion treatment for amblyopia: assessing the performance of the electronic occlusion dose monitor.
    Fronius M; Chopovska Y; Nolden J; Loudon SE; Lüchtenberg M; Zubcov A; Pepler L
    Strabismus; 2006 Jun; 14(2):65-70. PubMed ID: 16760110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of Interocular Suppression in Amblyopic Children during Electronically Monitored Occlusion Therapy: First Insight.
    Kehrein S; Kohnen T; Fronius M
    Strabismus; 2016 Jun; 24(2):51-62. PubMed ID: 27220458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectively monitored patching regimens for treatment of amblyopia: randomised trial.
    Stewart CE; Stephens DA; Fielder AR; Moseley MJ;
    BMJ; 2007 Oct; 335(7622):707. PubMed ID: 17855283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?
    Cleary M
    Br J Ophthalmol; 2000 Jun; 84(6):572-8. PubMed ID: 10837378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electronic monitoring of occlusion treatment for amblyopia in patients aged 7 to 16 years.
    Fronius M; Bachert I; Lüchtenberg M
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1401-8. PubMed ID: 19415317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of monitoring compliance with intermittent occlusion therapy glasses for amblyopia treatment.
    Wang J; Jin J; Malik A; Shoge R; Meiyeppen S; Pang Y; Yin K; Allen M; Scombordi B; Soni A; Neely DE; Januschowski K
    J AAPOS; 2019 Aug; 23(4):205.e1-205.e5. PubMed ID: 31271842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.
    Kuhli-Hattenbach C; Koss MJ; Kohnen T; Fronius M
    Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):2021-8. PubMed ID: 26100453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Amblyopia Using Personalized Dosing Strategies: Statistical Modelling and Clinical Implementation.
    Wallace MP; Stewart CE; Moseley MJ; Stephens DA; Fielder AR;
    Strabismus; 2016 Dec; 24(4):161-168. PubMed ID: 27929726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patching for Amblyopia: A Novel Occlusion Dose Monitor for Glasses Wearers to Track Adherence.
    Ahmad TR; Martinez MC; Tahir S; Nyong'o OL
    J Binocul Vis Ocul Motil; 2022; 72(2):69-76. PubMed ID: 35104201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractive adaptation and efficacy of occlusion therapy in untreated amblyopic patients aged 12 to 40 years.
    Simonsz-Tóth B; Joosse MV; Besch D
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):379-389. PubMed ID: 30397791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS).
    Stewart CE; Fielder AR; Stephens DA; Moseley MJ
    Br J Ophthalmol; 2002 Aug; 86(8):915-9. PubMed ID: 12140215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occlusion dose monitoring in amblyopia therapy: status, insights, and future directions.
    Stewart CE; Moseley MJ; Georgiou P; Fielder AR
    J AAPOS; 2017 Oct; 21(5):402-406. PubMed ID: 28890077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance with the prescribed occlusion treatment for amblyopia.
    Vagge A; Nelson LB
    Curr Opin Ophthalmol; 2017 Sep; 28(5):454-459. PubMed ID: 28617688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia.
    Holmes JM; Edwards AR; Beck RW; Arnold RW; Johnson DA; Klimek DL; Kraker RT; Lee KA; Lyon DW; Nosel ER; Repka MX; Sala NA; Silbert DI; Tamkins S;
    J AAPOS; 2005 Apr; 9(2):129-36. PubMed ID: 15838439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing visual rehabilitation after occlusion therapy in unilateral amblyopia in children.
    Menon V; Chaudhuri Z; Saxena R; Gill K; Sachdeva MM
    Indian J Med Res; 2005 Dec; 122(6):497-505. PubMed ID: 16518000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.